SOURCE: ICAP Patent Brokerage

ICAP Patent Brokerage

November 20, 2015 13:00 ET

Cardioplegia, Venous Drainage, and Ventriculotomy Cannulation Patents Available From ICAP Patent Brokerage

ICAP Patent Brokerage Announces for Sale Patents Disclosing the Next Generation in Cardioplegia Instrumentation

NEW YORK, NY--(Marketwired - November 20, 2015) - ICAP Patent Brokerage announces for sale patents disclosing the next generation in cardioplegia instrumentation -- cannulation of a patient's heart during cardiopulmonary bypass. This portfolio is available from Indian Wells Medical, Inc. as part of the December 2015 Cardiovascular Patent Auction. The live virtual auction will opening for bidding on Tuesday, December 8th at 9 am PST and will have a bidding deadline of December 10th at 5 pm PST. The auction is a sealed bid format, and the highest value bids above reserve price will win each respective technology for sale.

Indian Wells Medical, Inc. is led by Jay Lenker, Ph.D., its Co-Founder, President and CEO. Dr. Lenker consulted and served as VP of Scientific Affairs for MicroVention, Inc., a startup company developing products for the treatment of cerebrovascular aneurysms and has consulted and has helped lead many startup companies in various capacities. See the inventor biography for Dr. Lenker here. Dr. Lenker has participated in a live Inventor Q&A session for this technology. A recording of this call can be found here.

"Indian Wells Medical has provided a meaningful and novel technology offering for cardioplegia," says Peter Johnson, Senior Vice President for Medical Transactions at ICAP Patent Brokerage. "It is an important portfolio and innovation for any company providing products for cardiac bypass surgery."

Key Characteristics & Benefits
The portfolio of three patents and 1 pending patent application is directed to a system for cannulating the vena cava of a patient during cardiopulmonary bypass procedures. Such cannulation is necessary for drainage of venous blood from the patient so that it may be oxygenated and pumped back to the patient to perfuse tissues during cardiac surgery and, more specifically, during periods of ischemic cardiac arrest or dysfunction. The device of the present invention not only provides venous drainage for cardiopulmonary bypass, but also performs the function of routing cardioplegic solution through the heart in the retrograde direction. Such cardioplegia provides protection to the heart during periods of ischemic cardiac arrest. This invention replaces a plurality of cannulae currently used for open-heart surgery, thus simplifying the surgical field and improving visibility of the heart. The device allows for the delivery of retrograde cardioplegia to the coronary circulation of both the right and the left side of the heart. The device further includes protection mechanisms to prevent overinflation or excessive pressurization of the right atrium during retrograde delivery of cardioplegia solution.

See the technical description of the Cardioplegia, Venous Drainage, and Ventriculotomy Cannulation IP sales offering.

Sample forward or rearward citing companies include Abbott Laboratories, Medtronic Plc, Johnson & Johnson, Fujifilm Holdings Corp.

To learn more about the intellectual property available for sale in this portfolio:
Contact Michelle Tyler of ICAP Patent Brokerage at (312) 327-4438 or via email at michelle(at)icapip(dot)com.

If you would like to sell or auction a patent portfolio, visit our website to make a patent portfolio submission:

Follow us on Twitter (@ICAP_IP) and join our LinkedIn group.

About ICAP Patent Brokerage
ICAP Patent Brokerage is the world's largest intellectual property brokerage and patent auction firm, leveraging the talents of experienced patent brokers to match buyers and sellers for the sale of patents and other intellectual property assets. With multiple transaction platforms and unparalleled industry knowledge, including experience with trademarks, brands, intellectual property licensing, and UCC sales, ICAP Patent Brokerage is the global leader in the transaction of intellectual property.

Image Available:

Contact Information

  • Media Contact
    Sarah Saites
    (312) 327-4437